Ganaxolone demonstrated a greater reduction in seizure frequency (-61.5%) compared to placebo (-24.0%) after the 17 weeks, but the difference did not reach statistical significance (p = 0.17).
← all excerpts
The Emerging Role of Neurosteroids: Novel Drugs Brexanalone, Sepranolone, Zuranolone, and Ganaxolone in Mood and Neurological Disorders.
1
0.1700
0.1700